Authors:
Gotsman, I
Israeli, D
Alper, R
Rabbani, E
Engelhardt, D
Ilan, Y
Citation: I. Gotsman et al., Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice, INT J CANC, 97(1), 2002, pp. 52-57
Authors:
Gershoni-Baruch, R
Dagan, E
Israeli, D
Kasinetz, L
Kadouri, E
Friedman, E
Citation: R. Gershoni-baruch et al., Association of the C677T polymorphism in the MTHFR gene with breast and/orovarian cancer risk in Jewish women, EUR J CANC, 36(18), 2000, pp. 2313-2316
Authors:
Amson, R
Lassalle, JM
Halley, H
Prieur, S
Lethrosne, F
Roperch, JP
Israeli, D
Gendron, MC
Duyckaerts, C
Checler, F
Dausset, J
Cohen, D
Oren, M
Telerman, A
Citation: R. Amson et al., Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice, P NAS US, 97(10), 2000, pp. 5346-5350
Authors:
Garcia, L
Peltekian, E
Pastoret, C
Israeli, D
Armande, N
Parrish, E
Citation: L. Garcia et al., Computerised dystrophic muscle simulator: Prospecting potential therapeutic strategies for muscle dystrophies using a virtual experimental model, J GENE MED, 1(1), 1999, pp. 43-55
Authors:
Elkeles, A
Juven-Gershon, T
Israeli, D
Wilder, S
Zalcenstein, A
Oren, M
Citation: A. Elkeles et al., The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor, MOL CELL B, 19(4), 1999, pp. 2594-2600
Authors:
Tomasevic, G
Shamloo, M
Israeli, D
Wieloch, T
Citation: G. Tomasevic et al., Activation of p53 and its target genes p21(WAF1/Cip1) PAG608/Wig-1 in ischemic preconditioning, MOL BRAIN R, 70(2), 1999, pp. 304-313
Authors:
Roperch, JP
Lethrone, F
Prieur, S
Piouffre, L
Israeli, D
Tuynder, M
Nemani, M
Pasturaud, P
Gendron, MC
Dausset, J
Oren, M
Amson, RB
Telerman, A
Citation: Jp. Roperch et al., SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21(Waf1), P NAS US, 96(14), 1999, pp. 8070-8073
Authors:
Miiller, M
Wilder, S
Bannasch, D
Israeli, D
Lehlbach, K
Li-Weber, M
Friedman, SL
Galle, PR
Stremmel, W
Oren, M
Krammer, PH
Citation: M. Miiller et al., p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs, J EXP MED, 188(11), 1998, pp. 2033-2045